维普中文期刊产品整合服务
27篇 您的检索式:作者名="ENGERT C"
    题名 作者 年代 出处 被引量
1Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease显示文摘Clee S M Zwinderman A H Engert J C 2001Circulation2001,103,9:1
25'flanking varians of resistin are associated with obesity显示文摘ENGERT J C VOHL M C WILLIAMS S M 2002Diabetes2002,51,5:1
3Successful peripheral blood stem cell mobilization with etoposide (VP-16) in patients with relapsed or resistant lymphoma who failed cyclophosphamide mobilization 显示文摘Reiser M Josting A Draube A Mapara MY Scheid C Chemnitz J Tesch H Wolf J Diehl V Sohngen D Engert A 1999Bone Marrow Transplant1999,23,12:1
4Dexa-BEAM is not effective in patients with relapsed or resistant aggressive high-grade non-Hodgkin's lymphoma 显示文摘Reiser M Josting A Dias Wickramanayake P Draube A Scheid C Tesch H Wolf J Diehl V Engert A 1999Leuk Lymphoma1999,33,34:1
5Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappaB显示文摘Heck S Lezoualc'h F Engert S Behl C J Biol Chem0,274,:1
65' flanking variants of resistin are associated with obesity显示文摘Engert J C Vohl M C Williams S M 2002Diabetes2002,51,5:1
75' flanking variants of resistin are associated with obesity显示文摘Engert J C Vohl M C Williams S M 2002Diabetes2002,51,5:1
8Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): A randomised, open-label, phase 3 non-inferiority trial 显示文摘Engert A Haverkamp H Kobe C 2012Lancet2012,379,9828:1
9Reduced-intensity chemothera- py and PET-guided radiotherapy in patients with advanced stage Hodgkin' s lymphoma( HD15 trial) : a randomised, open-label, phase 3 non-inferiority trial显示文摘Engert A Haverkamp H Kobe C 2012Lancet2012,379,9828:1
10Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease显示文摘 ZWINDERMAN A H ENGERT J C 2001Circulation2001,103,:1
11Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): A randomised, open-label, phase 3 non-inferiority trial 显示文摘Engert A Haverkamp H Kobe C 2012Lancet2012,379,9828:1
12Common genetic variation in ABCA1 Is associated with altered lipoprotein levels and a modified risk for coronary artery disease显示文摘CLEE S M ZWINDERMAN A H ENGERT J C 2001Circulation2001,3,:1
13Assessment of residual bulky tumor using FDG-PET in patients with advanced-stage Hodgkin lymphoma after completion of chemotherapy;final report of the GHSG HD15 trial显示文摘Engert A Kobe C Markova J 0,,:1
14Reduced-intensity chemotherapy and PET- guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): A randomised, open-label, phase 3 non-inferiority trial 显示文摘Engert A Haverkamp H Kobe C 2012Lancet2012,379,9828:1
15Proliferation precedes differentiation in IGF-I-stimulated myogenesis显示文摘 BERGLUND E ROSENTHAL N 1996J Cell Biol1996,135,:1
16Financial market turmoil and central bank intervention显示文摘W ENGERT J SELODY C WILKINS 2008Financial System Review2008,,6:1
17Common genetic variation in abca1 is associated with altered lipoprotein levels and amodified risk for coronary artery disease显示文摘CLEE S M ZWINDERMAN A H ENGERT J C 2001Circulation2001,103,:1
18Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with ad- vanced stage Hodgkin's lymphoma( HD15 trial): a randomised, open-label, phase 3 non-inferiority trial 显示文摘Engert A Haverkamp H Kobe C 2012Lancet2012,379,9828:1
19Assessment of residual bulky tumor using FDG-PET in patients with advanced-stage Hodgkin lymphoma after completion of chemotherapy: final report of the GHSG HD15 trial 显示文摘Engert A Kobe C Markova J 2010Blood (ASH Annual Meeting Abstracts)2010,116,:1
20Radiation induced DNA double-strand breaks in radiology显示文摘KUEFNER M A BRAND M ENGERT C 2015Rofo2015,187,10:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费